Scalp cooling is a proven approach to reduce chemotherapy-induced alopecia that has been used successfully by thousands of patients worldwide for several decades.
SCALP COOLING
WHAT IS SCALP COOLING
Scalp cooling is a proven approach to reduce chemotherapy-induced alopecia that has been used successfully by thousands of patients worldwide for several decades. Reduced temperature results in a decreased blood flow to the scalp area so that less chemotherapy reaches the hair cells. Hair cells are therefore not exposed to the full dose of chemotherapy and may be able to survive the chemotherapy treatment. As a result, hair is less likely to fall out.
WHAT IS SCALP COOLING
Two physiologic reactions occur during scalp cooling:
1. Reduced blood flow–vasoconstriction in the localized scalp area limits the amount of chemotherapy agent delivered to the scalp and hair follicles.
2. Reduced reaction rate – the lower scalp temperature decreases metabolism causing normal cellular activity in the localized scalp area to slow dramatically. Fewer chemotherapy agents are then absorbed by the hair cells and damage is significantly
WHY SCALP COOLING MATTERS
A patient’s hair can be a major part of their identity, and many patients rate hair loss as one of the most devastating side effects of chemotherapy. Chemotherapy-induced alopecia is an unwelcome reminder of disease, one that can negatively affect self-image, confidence, overall sense of well-being and a patient’s attitude toward treatment.
Hair loss is no longer inevitable. The DigniCap Scalp Cooling System is a proven approach to reduce chemotherapy-induced alopecia, used successfully by thousands of patients worldwide to maintain privacy, self-esteem and control during a critical period of treatment.
THE DIGNICAP SCALP COOLING SYSTEM
DigniCap offers patients the ability to reduce hair loss from certain chemotherapy treatments and is FDA cleared for patients with solid tumors.
The DigniCap Scalp Cooling System consists of a computerized cooling unit managed through a touch screen display and an attached cooling cap. Temperature regulated coolant continuously circulates though specially designed channels in the cooling cap. The ability to maintain continuous, direct contact between the cooling cap and scalp for a consistent treatment temperature is a key factor in the effectiveness of DigniCap.
There are 2 models of The DigniCap Scalp Cooling System, the NEW DigniCap Delta and DigniCap C3. Both systems provide effective scalp cooling, but the machine, caps and business models are different.
CLICK HERE for more information on the NEW DigniCap Delta – FDA cleared 2019, CE Mark 2019
CLICK HERE for more information on DigniCap C3 – CE Mark 2001, FDA cleared 2015
Dignitana AB produces
The DigniCap
Scalp Cooling System to minimize hair loss from chemotherapy.
CLINICAL RESSOURCES
Learn more about The DigniCap Scalp Cooling System at dignicap.com
For Service and Supplies, CLICK HERE.
PATIENT STORIES
Learn more about The DigniCap Scalp Cooling System at dignicap.com
PATIENTS OUTSIDE THE U.S.
There are two DigniCap devices in use outside the U.S.. Select the system you are using below.
DigniCap Delta Patient Resources
PATIENT RESOURCES & TRAINING
The DigniCap Scalp Cooling System is FDA cleared to minimize hair loss in patients with solid tumors undergoing chemotherapy.
There are currently two models of The DigniCap Scalp Cooling System. Depending on your facility, you will either use the DigniCap C3 or DigniCap Delta. Both systems provide effective scalp cooling, but the machine and caps are different.
PATIENTS IN THE U.S.
DigniCap Delta Patient Resources
Patient Support Center
Our Support Center hours are Monday – Friday from 7 am – 6 pm, Central Time (U.S.), excluding holidays. Email or web inquiries received during this time will receive a reply within 2 hours. Voicemails that are left during business hours will be returned by end of the business day. After hours, your inquiry will be returned within 24 hours, or by 11 am the next business day.
For the fastest response, submit a support ticket through the Patient Support Center.
Please note, per HIPAA regulations, providing your phone number and/or e-mail address constitutes your agreement that Dignitana may leave a voicemail at the phone number you provide or answer your question via the e-mail you provide.
DigniCap C3 Patient Resources